Jake June-Koo Lee

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases

  Journal of Thoracic Oncology · 2025-10-24 · 1 citations

• Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA

  Nature · 2025-10-01 · 10 citations

• Integrated histopathologic modeling of detailed tumor subtypes and actionable biomarkersPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-08-16

• Complementary modes of resistance to <i>EGFR</i> TKI in lung adenocarcinoma through MAPK activation and cellular plasticityPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-05-10 · 2 citations

• Abstract 2847: Patterns of APOBEC3-mediated chromosomal rearrangements in solid cancers

  Cancer Research · 2025-04-21

• Figure 3 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Supplementary Tables S1-S13 from Chromothripsis-Mediated Small Cell Lung Carcinoma

  2025-01-13

• Figure 7 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Figure 5 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Figure 2 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Supplementary Figures S1-S13 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Figure 4 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Data from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Figure 1 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Figure 6 from Chromothripsis-Mediated Small Cell Lung CarcinomaPreprint

  2025-01-13

• Chromothripsis-Mediated Small Cell Lung Carcinoma

  Cancer Discovery · 2024-08-26 · 44 citations

• Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNAPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2024-08-23 · 7 citations